{"entity":{"type":"insider","cik":"0001577539","url":"/insider/0001577539","json_url":"/insider/0001577539.json","name":"Wood Gavin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2014-12-30","last":"2025-09-03","span_basis":"filed_date"},"name_variants":[{"name":"Wood Gavin","source":"filing","n_filings":8,"first_seen":"2014-12-30","last_seen":"2025-09-03"}],"transactions":[{"id":4725602,"accession":"0001104659-25-087085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-087085","line_url":"/filing/0001104659-25-087085#line-1","is_derivative":false,"issuer_cik":"0001577539","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001577539","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares with a nominal value of GBP0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96000.0,"shares_display":"96,000","price_per_share":0.0099,"price_display":"0.01","price_state":"stated","total_value":950.4,"total_display":"950.40","total_whole":"950","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-03","scope":"insider"},{"id":6124835,"accession":"0001104659-22-064008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-064008","line_url":"/filing/0001104659-22-064008#line-1","is_derivative":false,"issuer_cik":"0001577539","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001577539","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares with a nominal value of GBP0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39000.0,"shares_display":"39,000","price_per_share":0.2904,"price_display":"0.29","price_state":"stated","total_value":11325.6,"total_display":"11,325.60","total_whole":"11,326","shares_owned_after":96000.0,"shares_owned_after_display":"96,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider"},{"id":3080880,"accession":"0001104659-20-136481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-136481","line_url":"/filing/0001104659-20-136481#line-1","is_derivative":false,"issuer_cik":"0001577539","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001577539","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares with a nominal value of GBP0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24000.0,"shares_display":"24,000","price_per_share":0.6896,"price_display":"0.69","price_state":"stated","total_value":16550.4,"total_display":"16,550.40","total_whole":"16,550","shares_owned_after":57000.0,"shares_owned_after_display":"57,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":2639588,"accession":"0001104659-20-079248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-079248","line_url":"/filing/0001104659-20-079248#line-1","is_derivative":false,"issuer_cik":"0001577539","issuer_name":"Adaptimmune Therapeutics PLC","issuer_ticker":"ADAP","issuer_name_source":null,"issuer_url":"/issuer/0001577539","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares with a nominal value of GBP0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33000.0,"shares_display":"33,000","price_per_share":1.62,"price_display":"1.62","price_state":"stated","total_value":53460.0,"total_display":"53,460.00","total_whole":"53,460","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-06-30","scope":"insider"},{"id":8948309,"accession":"0001140361-15-007810","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-15-007810","line_url":"/filing/0001140361-15-007810#line-5","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":11.4,"price_display":"11.40","price_state":"stated","total_value":14820.0,"total_display":"14,820.00","total_whole":"14,820","shares_owned_after":84159.0,"shares_owned_after_display":"84,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-18","scope":"insider"},{"id":8204447,"accession":"0001140361-15-002351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-002351","line_url":"/filing/0001140361-15-002351#line-2","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":11.77,"price_display":"11.77","price_state":"stated","total_value":264825.0,"total_display":"264,825.00","total_whole":"264,825","shares_owned_after":54362.0,"shares_owned_after_display":"54,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-21","scope":"insider"},{"id":8799894,"accession":"0001140361-15-001792","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-15-001792","line_url":"/filing/0001140361-15-001792#line-3","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10200.0,"shares_display":"10,200","price_per_share":10.77,"price_display":"10.77","price_state":"stated","total_value":109854.0,"total_display":"109,854.00","total_whole":"109,854","shares_owned_after":54362.0,"shares_owned_after_display":"54,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-14","scope":"insider"},{"id":6805704,"accession":"0001140361-14-046760","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-14-046760","line_url":"/filing/0001140361-14-046760#line-5","is_derivative":false,"issuer_cik":"0000913077","issuer_name":"AFFYMETRIX INC","issuer_ticker":"AFFX","issuer_name_source":null,"issuer_url":"/issuer/0000913077","owner_cik":"0001577539","owner_name":"Wood Gavin","owner_display_name":"Wood Gavin","owner_url":"/insider/0001577539","role":"Officer (EVP, Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18734.0,"shares_display":"18,734","price_per_share":10.2,"price_display":"10.20","price_state":"stated","total_value":191086.8,"total_display":"191,086.80","total_whole":"191,087","shares_owned_after":54362.0,"shares_owned_after_display":"54,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001621227","name":"Adaptimmune Therapeutics PLC","url":"/issuer/0001621227","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2020-06-30","last_seen":"2025-09-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000913077","name":"AFFYMETRIX INC","url":"/issuer/0000913077","role":"Officer (EVP, Chief Financial Officer)","n_filings":4,"first_seen":"2014-12-30","last_seen":"2015-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001577539","retrieved_at":"2026-08-25T05:33:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}